Indications and uses
temporarily relieves these symptoms due to hay fever or other upper respiratory allergies: runny nose itchy, watery eyes sneezing itching of the nose or throat
temporarily relieves these symptoms due to hay fever or other upper respiratory allergies: runny nose itchy, watery eyes sneezing itching of the nose or throat
adults and children 6 years and over 1 tablet daily; not more than 1 tablet in 24 hours children under 6 years of age ask a doctor consumers with liver or kidney disease ask a doctor
Original Prescription Strength Non-Drowsy*
Indoor and Outdoor Allergies
*When taken as directed. See Drug Facts Panel.
TAMPER EVIDENT: DO NOT USE IF BLISTER UNITS ARE TORN, BROKEN OR SHOW ANY SIGNS OF TAMPERING.
Loratadine USP, 10 mg
Antihistamine
temporarily relieves these symptoms due to hay fever or other upper respiratory allergies:
if you have ever had an allergic reaction to this product or any of its ingredients.
liver or kidney disease. Your doctor should determine if you need a different dose.
do not take more than directed. Taking more than directed may cause drowsiness.
an allergic reaction to this product occurs. Seek medical help right away.
ask a health professional before use
In case of overdose, get medical help or contact a Poison Control Center right away.
adults and children
| 1 tablet daily; not more
|
children under 6 years of age | ask a doctor |
consumers with liver
| ask a doctor |
Corn starch, lactose monohydrate and magnesium stearate.
1-800-848-0462
Manufactured for:
Mylan Pharmaceuticals Inc.
Morgantown, WV 26505 U.S.A.
Made in India
Code No.: MH/DRUGS/25/NKD/89
Distributed by:
Mylan Institutional Inc.
Rockford, IL 61103 U.S.A.
S-11333 R3
1/21
PRINCIPAL DISPLAY PANEL – 10 mg
NDC 51079-246-20
Loratadine
Tablets, USP
10 mg
Antihistamine
Original Prescription Strength Non-Drowsy*
Indoor and Outdoor Allergies
24 Hour Relief(See Uses section of enclosed leaflet)
*When taken as directed. See enclosed leaflet.
TAMPER EVIDENT: DO NOT USE IF BLISTER UNITS ARE
TORN, BROKEN OR SHOW ANY SIGNS OF TAMPERING.


| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 51079-246-01 | Loratadine | 1 in 1 BLISTER PACK | TABLET | 1 | 11 | |
| 51079-246-20 | Loratadine | 100 in 1 BOX, UNIT-DOSE | TABLET | 100 | 11 |
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 51079-246-01 | EA - Each | 51079-246 | adff317d-19f8-443c-9a3c-2aaa0c60c9f6 | 1 | 2013-06-04 |
| 51079-246-20 | EA - Each | 51079-246 | ee862795-d632-44eb-96af-f9374f529e97 | 1 | 2013-06-04 |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| LORATADINE | ACTIVE INGREDIENT | 7AJO3BO7QN | 3 | |
| LORATADINE | ACTIVE MOIETY | 7AJO3BO7QN | 3 | |
| LACTOSE MONOHYDRATE | INACTIVE INGREDIENT | EWQ57Q8I5X | 3 | |
| MAGNESIUM STEARATE | INACTIVE INGREDIENT | 70097M6I30 | 3 | |
| STARCH, CORN | INACTIVE INGREDIENT | O8232NY3SJ | 3 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 51079-246 | 51079-246-01, 51079-246-20 |
| 0378-8880 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| STARCH, CORN | O8232NY3SJ | IACT |
| LACTOSE MONOHYDRATE | EWQ57Q8I5X | IACT |
| MAGNESIUM STEARATE | 70097M6I30 | IACT |
| LORATADINE | 7AJO3BO7QN | ACTIB |
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | TABLET / ORAL | 980 mg | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | TABLET / ORAL | 980 mg | ||
| STARCH, CORN | STARCH, CORN | O8232NY3SJ | TABLET / ORAL | 1116 mg | ||
| STARCH, CORN | STARCH, CORN | O8232NY3SJ | TABLET / ORAL | 1116 mg | ||
| LACTOSE MONOHYDRATE | LACTOSE MONOHYDRATE | EWQ57Q8I5X | TABLET / ORAL | 4384 mg | ||
| LACTOSE MONOHYDRATE | LACTOSE MONOHYDRATE | EWQ57Q8I5X | TABLET / ORAL | 4384 mg | ||
| LACTOSE MONOHYDRATE | LACTOSE MONOHYDRATE | EWQ57Q8I5X | TABLET / ORAL | 4384 mg | ||
| STARCH, CORN | STARCH, CORN | O8232NY3SJ | TABLET / ORAL | 1116 mg | ||
| STARCH, CORN | STARCH, CORN | O8232NY3SJ | TABLET / ORAL | 1116 mg | ||
| LACTOSE MONOHYDRATE | LACTOSE MONOHYDRATE | EWQ57Q8I5X | TABLET / ORAL | 4384 mg | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | TABLET / ORAL | 980 mg | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | TABLET / ORAL | 980 mg |
All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A076154-001 | LORATADINE | LORATADINE | 10MG | TABLET / ORAL | 2003-08-20 |
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A076154-001 | LORATADINE | 10MG | TABLET / ORAL | 2003-08-20 | 84e616aacf4f… | ||
| 2026-08-18 06:07:40 | 2026-07 | A076154-001 | LORATADINE | 10MG | TABLET / ORAL | 2003-08-20 | caaa826d4ba7… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A076154-001 | LORATADINE | 10MG | TABLET / ORAL | 2003-08-20 | 011fe1cb6892… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A076154-001 | LORATADINE | 10MG | TABLET / ORAL | 2003-08-20 | 31067a03dcf5… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A076154-001 | LORATADINE | 10MG | TABLET / ORAL | 2003-08-20 | 6a471c1ec25d… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A076154-001 | LORATADINE | 10MG | TABLET / ORAL | 2003-08-20 | fd3edfee7708… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A076154-001 | LORATADINE | 10MG | TABLET / ORAL | 2003-08-20 | b8a1b40f171c… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A076154-001 | LORATADINE | 10MG | TABLET / ORAL | 2003-08-20 | 03ed91905a0d… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A076154-001 | LORATADINE | 10MG | TABLET / ORAL | 2003-08-20 | 2680178bc6a6… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A076154-001 | LORATADINE | 10MG | TABLET / ORAL | 2003-08-20 | 5bbf6a4d5a75… | ||
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A076154-001 | LORATADINE | 10MG | TABLET / ORAL | 2003-08-20 | d8e5a09893c0… | ||
| 2024-10-29 15:01 UTC | 2024-10 | A076154-001 | LORATADINE | 10MG | TABLET / ORAL | 2003-08-20 | d06236e962d9… | ||
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A076154-001 | LORATADINE | 10MG | TABLET / ORAL | 2003-08-20 | 79d66fd596c7… | ||
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A076154-001 | LORATADINE | 10MG | TABLET / ORAL | 2003-08-20 | 301d65b070ca… | ||
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A076154-001 | LORATADINE | 10MG | TABLET / ORAL | 2003-08-20 | 1e350fbaab3a… | ||
| 2024-05-31 18:47 UTC | 2024-05 | A076154-001 | LORATADINE | 10MG | TABLET / ORAL | 2003-08-20 | 8072bd15b7f6… | ||
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A076154-001 | LORATADINE | 10MG | TABLET / ORAL | 2003-08-20 | 5c6f7cd8ea54… | ||
| 2022-04-08 23:34 UTC | 2022-04 | A076154-001 | LORATADINE | 10MG | TABLET / ORAL | 2003-08-20 | 5d02ea3f76ae… | ||
| 2022-04-04 05:41 UTC | 2022-04 | A076154-001 | LORATADINE | 10MG | TABLET / ORAL | 2003-08-20 | 4b0b4de00fa7… | ||
| 2019-12-13 00:20 UTC | 2019-12 | A076154-001 | LORATADINE | 10MG | TABLET / ORAL | 2003-08-20 | 74a2ff9319b5… | ||
| 2022-03-09 01:35 UTC | 2022-03 | A076154-001 | LORATADINE | 10MG | TABLET / ORAL | 2003-08-20 | bb7c543d1eb4… | ||
| 2021-12-28 21:50 UTC | 2021-12 | A076154-001 | LORATADINE | 10MG | TABLET / ORAL | 2003-08-20 | 782e0a99824c… | ||
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | A076154-001 | LORATADINE | 10MG | TABLET / ORAL | 2003-08-20 | 87673890dc5c… | ||
| 2021-03-12 10:30 UTC | 2021-03 | A076154-001 | LORATADINE | 10MG | TABLET / ORAL | 2003-08-20 | 5aa47cf7b7d7… | ||
| 2020-12-22 03:56 UTC | 2020-12 | A076154-001 | LORATADINE | 10MG | TABLET / ORAL | 2003-08-20 | 8869cabd3fbd… | ||
| 2020-11-12 02:37 UTC | 2020-11 | A076154-001 | LORATADINE | 10MG | TABLET / ORAL | 2003-08-20 | c0c555d07b60… | ||
| 2019-12-14 00:12 UTC | 2019-12 | A076154-001 | LORATADINE | 10MG | TABLET / ORAL | 2003-08-20 | 3f01610625f2… | ||
| 2019-09-15 20:21 UTC | 2019-09 | A076154-001 | LORATADINE | 10MG | TABLET / ORAL | 2003-08-20 | b00525d2431f… | ||
| 2019-07-19 19:46 UTC | 2019-07 | A076154-001 | LORATADINE | 10MG | TABLET / ORAL | 2003-08-20 | ea99ee380514… | ||
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | A076154-001 | LORATADINE | 10MG | TABLET / ORAL | 2003-08-20 | 6a51e52b5d6a… | ||
| 2024-02-18 07:12 UTC | 2024-02 | A076154-001 | LORATADINE | 10MG | TABLET / ORAL | 2003-08-20 | 1c564ffb4f44… | ||
| 2023-12-20 04:57 UTC | 2023-12 | A076154-001 | LORATADINE | 10MG | TABLET / ORAL | 2003-08-20 | ea1830bbd6c7… | ||
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | A076154-001 | LORATADINE | 10MG | TABLET / ORAL | 2003-08-20 | a72a2bbeb626… | ||
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | A076154-001 | LORATADINE | 10MG | TABLET / ORAL | 2003-08-20 | 9b2671bbb829… | ||
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | A076154-001 | LORATADINE | 10MG | TABLET / ORAL | 2003-08-20 | a67488948f0b… | ||
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | A076154-001 | LORATADINE | 10MG | TABLET / ORAL | 2003-08-20 | 3f0d92c62455… | ||
| 2023-05-13 08:27 UTC | 2023-05 | A076154-001 | LORATADINE | 10MG | TABLET / ORAL | 2003-08-20 | 053a50430f4f… | ||
| 2023-01-26 05:58 UTC | 2023-01 | A076154-001 | LORATADINE | 10MG | TABLET / ORAL | 2003-08-20 | 3bdfa0b2c4d7… | ||
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | A076154-001 | LORATADINE | 10MG | TABLET / ORAL | 2003-08-20 | 3a93d1ddd44b… | ||
| 2022-10-28 04:53 UTC | 2022-10 | A076154-001 | LORATADINE | 10MG | TABLET / ORAL | 2003-08-20 | f41ea6bd6efb… |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Loratadine | LORATADINE | Mylan Institutional Inc. | 1fc9ddd1-393d-4fe2-a9e0-d192df7331db | 2025-07-22 | Warnings | 51079-246-01 51079-246-20 51079-246 51079024620 51079024601 3a865b90-4189-3e83-e063-6394a90aba53 1fc9ddd1-393d-4fe2-a9e0-d192df7331db |
| Loratadine | LORATADINE | Mylan Pharmaceuticals Inc. | 3b307aea-5a68-4c82-959a-cda4ffbd0a4a | 2013-11-15 | Warnings | 0378-8880 |
Adverse event summaries are temporarily unavailable. Other product information remains available.